Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Valeant Pharmaceuticals | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Valeant Pharmaceuticals

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Rajiv De Silva has been appointed chief operating officer of Specialty Pharmaceuticals, Valeant Pharmaceuticals International, effective January 5, 2009. Mr. De Silva will be responsible for overseeing the U.S., Canadian and Australian specialty pharmaceuticals operations.

“We are very pleased to have Rajiv join the Valeant team,” said J. Michael Pearson, chairman and chief executive officer of Valeant. “His experience in the global pharmaceutical industry and his track record on the operations side should serve as important assets to the Valeant team as we continue to focus our business on efficiency and profitability.”

Prior to joining the company, Mr. De Silva held various leadership positions with Novartis AG. Most recently, he served as president, Novartis Vaccines USA and head, Vaccines of the Americas. Mr. De Silva held these positions since 2007 and also played a key leadership role at Novartis’ Vaccines & Diagnostics Division and served as a member of the executive committee. From 2005 to 2007, he served as president, Novartis Pharmaceuticals Canada. He joined Novartis in 2003 as global head, strategic planning for Novartis Pharma AG, in Basel, Switzerland.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters